Most cure research aims to remove dormant HSV from nerve cells. Another idea is a “functional cure”: keeping the virus permanently switched off. This study from Anna Cliffe’s lab at the University of Virginia, with colleagues in Glasgow and Ottawa, published in Nature Communications, helps explain how that switch-off works.
What the researchers found
- When neurons were exposed to type I interferon, an early antiviral alarm signal, during the first infection, structures called PML nuclear bodies formed around the viral DNA.
- This led to more of a repressive chemical tag, H3K9me3, on the dormant viral genomes. It works like a long-term “off” label on DNA.
- A protein called ATRX, which is very abundant in neurons, reads that tag and stays bound to the viral DNA, preventing reactivation.
Why it matters
The conditions during the first infection leave an epigenetic memory on the virus that shapes how easily it wakes up later. The study identifies ATRX as a natural brake on reactivation, and a possible target for future treatments that strengthen that brake.
What to keep in mind
The experiments used mouse neurons grown in the lab. Whether the same mechanism controls reactivation in people, and whether it can be reinforced safely with a drug, are open questions.